<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03025425</url>
  </required_header>
  <id_info>
    <org_study_id>R16148_TAYS</org_study_id>
    <nct_id>NCT03025425</nct_id>
  </id_info>
  <brief_title>Palliation of Dyspnea With Mouth Piece Ventilation in AECOPD</brief_title>
  <official_title>Palliation of Dyspnea With Mouth Piece Ventilation in Acute Exacerbation of COPD Without Respiratory Insufficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tampere University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An uncontrolled feasibility study on using mouth piece ventilation in palliation of dyspnea&#xD;
      in subjects with acute exacerbation of COPD without acute hypercapnic respiratory failure.&#xD;
      Subjects are recruited from the local respiratory ward. The main outcomes are the compliance&#xD;
      of the subjects with the treatment and alleviation of dyspnea during the treatment period.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Difficulty in finding suitable patients&#xD;
  </why_stopped>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Actual">August 1, 2020</completion_date>
  <primary_completion_date type="Actual">August 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in dyspnea after initial period of using MPV</measure>
    <time_frame>5-60 min</time_frame>
    <description>Change in dyspnea after initial period of using MPV</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in dyspnea after 24 hours of using MPV</measure>
    <time_frame>24 hours</time_frame>
    <description>Change in dyspnea after 24 hours of using MPV</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of subjects having side-effects or not being compliant with MPV</measure>
    <time_frame>24 hours</time_frame>
    <description>Proportion of subjects having side-effects or not being compliant with MPV</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of subjects gaining from MPV</measure>
    <time_frame>24 hours</time_frame>
    <description>Proportion of subjects gaining from MPV</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of subjects willing to continue on MPV after the intervention</measure>
    <time_frame>24 hours</time_frame>
    <description>Proportion of subjects willing to continue on MPV after the intervention</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>COPD Exacerbation</condition>
  <condition>Dyspnea</condition>
  <arm_group>
    <arm_group_label>MPV-arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects use mouth piece ventilation (MPV) according to their will for 24 hours to alleviate dyspnea.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Trilogy 100 ® (Philips Respironics)</intervention_name>
    <description>Mouth piece Ventilation (MPV) using Trilogy 100 ® (Philips Respironics).</description>
    <arm_group_label>MPV-arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  a previous diagnosis of COPD&#xD;
&#xD;
          -  hospitalized due to acute exacerbation of COPD&#xD;
&#xD;
          -  at least moderate dyspnea (NRS = Numeric Rating Scale ≥ 4)&#xD;
&#xD;
          -  no acute hypoventilation (pH ≥ 7.35 and PCO2 ≤ 6.0 kPa)&#xD;
&#xD;
          -  able to understand the study and to give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  unable to participate and use MPV due to e.g. delirium or lack of co-operation&#xD;
&#xD;
          -  acute hypoventilation (pH &lt; 7.35 or PCO2 &gt; 6.0 kPa)&#xD;
&#xD;
          -  acute need for ventilatory support&#xD;
&#xD;
          -  the cause of the dyspnea can be successfully treated&#xD;
&#xD;
          -  unable to give informed consent&#xD;
&#xD;
          -  a previous chronic hypoxemic or hypercapnic respiratory insufficiency that has been&#xD;
             treated on a long-term basis also at home&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lauri Lehtimäki, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tampere University Hospital, Allergy centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dpt of Respiratory Medicine, Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <zip>33520</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>January 17, 2017</study_first_submitted>
  <study_first_submitted_qc>January 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 19, 2017</study_first_posted>
  <last_update_submitted>October 18, 2021</last_update_submitted>
  <last_update_submitted_qc>October 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tampere University Hospital</investigator_affiliation>
    <investigator_full_name>Lauri Lehtimäki</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyspnea</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

